Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study.

Can J Kidney Health Dis · 2016 · PMC4845385 · PMID 27119016

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

Three of the 56 patients who received an ESA >6 months duration at any time post transplant developed NODAT; however, this did not reach statistical significance ( p = 0.065).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.